Early Post-Registry Experience With Drug-Eluting Stents in the Superficial Femoral Artery

Conclusion: On mean 20-week follow-up, we have seen 92.3% primary patency and 96.2% secondary patency. A larger number of patients and longer follow-up will be required to determine the true real-world efficacy of this drug-eluting device, but early experience is encouraging and warrants continued trial.
Source: Vascular and Endovascular Surgery - Category: Surgery Authors: Tags: Original Manuscripts Source Type: research